Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study

Detalles Bibliográficos
Autores principales: Yamada, Hodaka, Yoshida, Masashi, Suzuki, Daisuke, Funazaki, Shunsuke, Nagashima, Shuichi, Masahiko, Kimura, Kiyoshi, Otsuka, Hara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981821/
https://www.ncbi.nlm.nih.gov/pubmed/36627460
http://dx.doi.org/10.1007/s13300-022-01365-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981821/
https://www.ncbi.nlm.nih.gov/pubmed/36627460
http://dx.doi.org/10.1007/s13300-022-01365-2

Ejemplares similares